To the Editor:
We read the recently published study on the physical and mental quality of life (QOL) in recurrent acute pancreatitis (RAP) patients [1] . It is a large sample study, which compared the QOL between RAP, chronic pancreatitis (CP), and non-disease controls. However, some of the study is confusing.
In the present study, RAP was defined by evidence of two or more documented attacks of acute pancreatitis (AP), but without imaging or histological evidence of chronic pancreatitis. However, the definition of RAP is still controversial. In some studies, RAP was defined as two or more well-documented separate episodes of pancreatitis that resolved with more than 3 months between attacks [2] . As pancreatic parenchymal changes may persist after the complete normalization of pancreatic enzymes and resolution of patient's symptoms, the definition is less specific if the interval between the acute attacks is short [3] . In some other studies, RAP was defined as more than two acute attacks within 1 year, as acute attacks after a long interval may have different etiologies [4] . Thus, patients included as "RAP" in the present study are "patients with two or more AP attacks" indeed, which are heterogeneous.
Endocrine insufficiency was concluded to have significant effect on Physical Component Summary in RAP patients. However, RAP patients may have transient endocrine insufficiency during the acute attack, but between episodes of pancreatitis, the blood glucose level was normal [3] . Here comes the question, what point in time the endocrine function was assessed. Is this endocrine insufficiency during acute attack or between episodes of pancreatitis?
The definition of endocrine insufficiency was also unclear. Are patients with impaired glucose tolerance also defined as endocrine insufficiency or just patients with diabetes mellitus (DM) included? Also, there are three types of DM, among which only type 3c is pancreatogenous. DM is a common disease with the prevalence of 0.84% in the United States, and type 2 DM accounted for 43% of total diabetes cases [5] . It is difficult to differentiate type 3c and type 2 DM. Thus, it is really confusing how endocrine insufficiency could be identified in the present study.
In conclusion, this is a large sample study about the physical and mental QOL in RAP patients. However, definition of RAP, endocrine insufficiency, and point of time to estimate endocrine function were unclear.
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